Buckle Up: DOJ Initiates Rulemaking to Reschedule Marijuana
FDA Law
MAY 21, 2024
The 2016 reviews concluded that marijuana continued to meet schedule I criteria for having a high potential for abuse, no currently accepted medical use in treatment in the U.S., and lacked accepted safety for use under medical supervision. 21 U.S.C. § 21 U.S.C. § Schedules of Controlled Substances: Rescheduling of Marijuana, 89 Fed.
69 
Let's personalize your content